Ardaman Shergill to Immunotherapy
This is a "connection" page, showing publications Ardaman Shergill has written about Immunotherapy.
Connection Strength
0.074
-
Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma. Cancer Rep (Hoboken). 2024 Dec; 7(12):e70037.
Score: 0.040
-
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer. J Immunother Cancer. 2022 06; 10(6).
Score: 0.034